A Single Academic Center\u27s Experience with Direct Access Colonoscopy by Israilevich, Rachel et al.
Thomas Jefferson University 
Jefferson Digital Commons 
Phase 1 Class of 2023 
2-2021 






David Kastenberg, MD 
Follow this and additional works at: https://jdc.jefferson.edu/si_ctr_2023_phase1 
 Part of the Translational Medical Research Commons 
Let us know how access to this document benefits you 
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital 
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is 
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections 
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested 
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been 
accepted for inclusion in Phase 1 by an authorized administrator of the Jefferson Digital Commons. For more 
information, please contact: JeffersonDigitalCommons@jefferson.edu. 
Efficiency and Quality of Direct 
Access Colonoscopy (DAC) is non-
inferior to Office Scheduled 
Colonoscopy (OSC)
Rachel Israilevich, Mary White,  Sophia Lam, Michael McCarthy, Benjamin Chipkin, 
Vasil Mico, Eric Abrams, David Kastenberg, MD*
(*) indicates primary project advisor
• No disclosures
Introduction & Objectives
• Colorectal cancer: #3 most common cancer1
– Often preventable- colonoscopy is preferred screening method
• Proven to diminish incidence of colorectal CA2
• Traditionally, patients appropriate for screening or surveillance are 
referred to GIs for a pre-procedure consultation3
• Recently, PCPs directly refer low-risk pts for DACs without pre-
procedure consultation4-6
– DACs decrease interval to colonoscopy, increase screening and 
surveillance compliance, and decrease patient cost7
• Given that millions of colonoscopies in the U.S. are being done via 
DAC, there is a gap in understanding their efficacy and quality as 
compared to OSC
– There are limited, conflicting evidence-based recommendations regarding 




– How does Jefferson’s DAC program, unique in its 
algorithmic approach utilizing EMR, nurse practitioner, 
and navigator as needed, compare in its performance 
to that of traditional OSC?  
• Hypothesis:
– We hypothesize that the efficiency and quality of 
Jefferson’s DAC program is non-inferior to OSC when 
appropriate evidence-based approaches are taken 
towards assessing individual patient’s needs.
Methods
• Study design: retrospective medical chart-review
• Population: 1823 patients aged 45-75, with a life expectancy of 10+ years, 
who have had a DAC for screening or surveillance from June 1, 2018 – July 31, 
2019
• Intervention: DAC
• Comparison group: 828 patients aged 45-75, with a life expectancy of 10+ 
years, who have had a OSC for screening or surveillance from June 1, 2018 –
July 31, 2019
• Outcome: compare prep adequacy, polyp detection rates, recall status, 
colonoscopy withdrawal time, cancellation rate, # of days from patient 
contact w/ GI office to colonoscopy, colonoscopy completion rate, and rate of 
follow-up between DAC and OSC groups (and hopefully prove non-inferiority)
• Data source and collection: EPIC
• Rationale: To analyze available patient data in the newly implemented DAC 
program and establish non-inferiority for evidence-based continuation




• Greater proportion of patients identifying as Black






Age (years), mean (sd) 58 (7) 61 (8) 0.001
Age (years), n (%) 0.001
40-49 50 2.7% 48 5.8%
50-59 1053 57.8% 282 34.1%
60-69 580 31.8% 356 43.0%
70+ 140 7.7% 142 17.1%
Sex, n (%) 0.586
Male 783 43.0% 365 44.1%
Female 1040 57.0% 463 55.9%
Race, n (%) 0.001*
White 642 35.2% 377 45.5%
Black 900 49.4% 270 32.6%
Latino/Hispanic 89 4.9% 91 11.0%
Other 192 10.5% 90 10.9%
Indication, n (%) 0.001*
Screening 1609 88.3% 476 57.5%
Surveillance 214 11.7% 352 42.5%
Results
• Mean time to colonoscopy less for DAC than OSC
• Similar bowel prep b/w DAC + OSC






Time to colonoscopy 
(days), mean (sd)





6 91 8.0% 52 11.0%
7 220 19.2% 104 22.0%
8 504 44.1% 204 43.1%
9 328 28.7% 113 23.9%
Any Polyp, n (%) 726 63.5% 324 68.5% 0.056
Cancer, n (%) 3 0.3% 2 0.4% 0.597
Results
• Successful colonoscopy (SC):
– Black patients were less likely to achieve SC
– Age, sex, identifying as Latino/Hispanic or other races, and screening 








RR (95% CI) P
Age (yrs), n (%) 0.511
40-49 98 63 64.3% 1 Ref
50-59 1335 810 60.7% 0.89 (0.76, 1.04)
60-69 936 573 61.2% 0.89 (0.77, 1.04)
70+ 282 170 60.3% 0.77 (0.75, 1.06)
Sex, n (%) 0.409
Male 1148 713 62.1% 1 Ref
Female 1503 903 60.1% 0.97 (0.92, 1.04)
Race, n (%) 0.001*
White 1019 653 64.1% 1 Ref
Black 1170 645 55.1% 0.85 (0.79, 0.91)
Latino/Hispanic 180 124 68.9% 1.08 (0.97, 1.21)
Other 282 194 68.8% 1.05 (0.96, 1.15)
Indication, n (%) 0.123
Screening 2085 1265 60.7% 1 Ref
Surveillance 566 351 62.0% 1.07 (0.98, 1.15)
Results
• For both DAC and OSC, patient no-show or cancellation was the 
most common reason for unsuccessful colonoscopy
• Proportionally:
– More DAC patients cancelled or no-showed 
– More OSC patients scheduled >90 days from contact with GI office  





Reason, n (%) 0.001*
Patient cancellation or no-show 428 62.9% 121 34.1%
Cancellation due to prep or inadequate prep 79 11.6% 59 16.6%
Other / Unknown 77 11.3% 79 22.3%
Scheduled too far out 51 7.5% 80 22.5%
Financial or insurance clearance 32 4.7% 8 2.3%
Provider cancellation 13 1.9% 8 2.3%
Conclusions
• DAC is non-inferior to OSC for primary endpoint of CC [DAC vs OSC: 62.7% 
vs 57.1%, RR 1.10, 95% LCL 1.04, P=0.001] 
– CC for DAC remained non-inferior to OSC when adjusted for age, sex, 
race, and indication [DAC vs OSC: 62.7% vs 57.1%, RR 1.16, 95% LCL 1.09, 
P=0.001] 
– Black patients less likely to achieve CC
• Quality (measured by polyp detection) was high and non-inferior for DAC
• Cancellation or no-show was the most common reason for UC
• In current literature, DAC programs are not standardized and there is a 
disparity between the evidence supporting standard of care OSC and DAC 
with respect to efficacy and quality
• Hospitals and tertiary care centers continuously strive to find evidence 
based methods to construct DAC programs
• Our results support the continuation of the DAC program and help guide 
future improvements to ensure optimal patient care
Future Directions
• Replication of this study in different tertiary-
care centers to support non-inferiority 
• Identifying reasons for differences across races 
in reaching the primary endpoint of 
completed colonoscopy (CC) 
– Can the DAC program help minimize this 
difference?
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